Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)
Completed · Phase 2
Conditions studied: Non-Hodgkin's Lymphoma (NHL)
In brief
The primary objective of the study is to determine the efficacy, as measured by overall response (complete response + partial response) of bendamustine in combination with ofatumumab in previously untreated patients with indolent B-Cell Non-Hodgkin's Lymphoma (NHL).
Key facts
- Study ID
- NCT01108341
- Run by
- Cephalon
- People needed
- 50
- Starts
- 2010-05-01
- Expected to finish
- 2011-10-01
- Last updated by the study team
- 2012-08-28
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Birmingham Hematology and Oncology Associates, LLC — Birmingham, Alabama, United States
- University of Alabama at Birmingham — Birmingham, Alabama, United States
- Tower Cancer Research Foundation — Beverly Hills, California, United States
- Hematology Oncology, P.C. — Stamford, Connecticut, United States
- University Cancer Institute — Boynton Beach, Florida, United States
- Florida Cancer Institute - New Hope — New Port Richey, Florida, United States
- Dublin Hematology Oncology Care P.C. — Dublin, Georgia, United States
- Northwest Georgia Oncology Center — Marietta, Georgia, United States
- Georgia Cancer Specialists — Tucker, Georgia, United States
- Cancer Care and Hematology Specialists of Chicagoland — Niles, Illinois, United States
- Siouxland Hematology-Oncology Assoc. LLP — Sioux City, Iowa, United States
- Kentucky Cancer Clinic — Hazard, Kentucky, United States
- Carroll County Cancer Center — Westminster, Maryland, United States
- Columbia Comprehensive Cancer Care Clinic — Jefferson City, Missouri, United States
- Nevada Cancer Institute — Las Vegas, Nevada, United States
- Somerset Hematology Oncology Associates — Somerville, New Jersey, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Monter Cancer Center — Lake Success, New York, United States
- Mid Dakota Clinic — Bismarck, North Dakota, United States
- Oregon Health Sciences University — Portland, Oregon, United States
- University of Pittsburgh Medical Center - Cancer Institute — Pittsburgh, Pennsylvania, United States
- Cancer Centers of the Carolinas — Greenville, South Carolina, United States
- The West Clinic — Memphis, Tennessee, United States
- Texas Oncology, P.A. — Bedford, Texas, United States
- MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.